Case report of a laryngeal squamous cell carcinoma treated with artesunate
Authors:
Open Access
- 1 January 2002
- journal article
- Published by National Library of Serbia
- Vol. 10 (4) , 279-280
Abstract
This present report describes the treatment of a laryngeal squamous cell carcinoma patient with the water-soluble artemisinin analog, artesunate Artemisinin is a novel anti-cancer drug with demonstrated results in killing cancer cells. Artesunate injections and tablets were administered to the patient over a period of nine months. The tumor was significantly reduced (by 70%) after two months of treatment. Overall, the artesunate treatment of the patient was beneficial in prolonging and improving the quality of life Artemisinin and its analogs offer promise for cancer therapy.Keywords
This publication has 4 references indexed in Scilit:
- Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cellsLife Sciences, 2001
- Oral administration of dihydroartemisinin and ferrous sulfate retarded implanted fibrosarcoma growth in the ratCancer Letters, 1995
- Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrinCancer Letters, 1995
- Hemin-catalyzed decomposition of artemisinin (qinghaosu)Biochemical Pharmacology, 1992